UNH stock performance decline

PARAGRAPH 1 --- UnitedHealth Group (UNH) stock has declined significantly, down over 33% and more than 50% from its 52-week high. This downturn was driven by rising medical costs and a shift in member mix, as highlighted by Latitude Investment Management in their Q4 2025 investor letter. Additionally, Berkshire Hathaway's exit from UNH shares in May 2026 contributed to the stock's decline, with Reuters reporting a 2% drop on that day.

PARAGRAPH 2 --- The healthcare sector, particularly managed care providers like UNH, is affected. Rising medical costs and changing member demographics put pressure on earnings, leading to valuation repricing. UNH's medical care ratio surged to 89% in 2025, up from around 80% five years ago. This increased cost structure impacts UNH's profitability and investor sentiment, driving a sell-off in the stock.

PARAGRAPH 3 --- To watch next, investors should focus on UNH's Q2 earnings release, scheduled for July 18, 2026. This will provide an update on the company's cost management and earnings trajectory. Additionally, the evolution of UNH's member mix and any changes in medical cost trends will be crucial to monitor. Lastly, any further actions by major shareholders like Berkshire Hathaway could also influence UNH's stock performance.